Sosimerasib is an orally active inhibitor targeting KRAS G12C mutations. It exhibits significant functional inhibitory effects on mutant KRAS G12C proteins, making it a valuable tool for studying signaling pathways involved in cancer progression. This compound is particularly relevant for research applications focused on non-small cell lung cancer.
Sosimerasib is an orally active inhibitor targeting KRAS G12C mutations. It exhibits significant functional inhibitory effects on mutant KRAS G12C proteins, making it a valuable tool for studying signaling pathways involved in cancer progression. This compound is particularly relevant for research applications focused on non-small cell lung cancer.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: